In the ADVANCE study, a case-cohort study including 3865 patients with T2DM and baseline CAD or risk factors, IL-6 levels, but not CRP or FIB levels, were significant to the prediction of macro-vascular events and mortality [40]. The gene discussed is IL6; the disease is type 2 diabetes mellitus.